Targeted PARP Inhibition Combined with FGFR1 Blockade is Synthetically Lethal to Malignant Cells in Patients with Pancreatic Cancer.

Autor: Lai, Shiue-Wei1,2,3 (AUTHOR) xsurfer@office365.ndmctsgh.edu.tw, Bamodu, Oluwaseun Adebayo4,5 (AUTHOR) 16625@s.tmu.edu.tw, Chen, Jia-Hong1,2,3 (AUTHOR) ndmc_tw.tw@yahoo.com.tw, Wu, Alexander TH6,7 (AUTHOR) chaw1211@tmu.edu.tw, Lee, Wei-Hwa5,8 (AUTHOR), Chao, Tsu-Yi1,2,4,5,9 (AUTHOR) ctyeh@s.tmu.edu.tw, Yeh, Chi-Tai1,2,4,5,10 (AUTHOR) ctyeh@s.tmu.edu.tw
Zdroj: Cells (2073-4409). Apr2020, Vol. 9 Issue 4, p911. 1p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje